Imperial College Centre for Psychedelic Research, formally established in 2019 from a research program active since 2012 at Imperial College London, uses brain imaging (PET/fMRI) to investigate consciousness mechanisms under psychedelics and trials psilocybin for depression. Its institutional prestige, neuroimaging methodology, and peer-reviewed publications make it one of the world's leading centers for psychedelic consciousness research.